EFL039
Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center, in a discussion about a recent article in The Journal of Clinical Endocrinology & Metabolism with Ashok Balasubramanyam, MD, from Baylor College of Medicine and guest expert Taylor Triolo, MD, from University of Colorado. The article featured this month, by Wright et al, was first published online in JCEM in March 2023: “Longitudinal MRI Shows Progressive Decline in Pancreas Size and Altered Pancreas Shape in Type 1 Diabetes.”
Meet the Speakers
Taylor Triolo, MD, is a board-certified pediatric endocrinologist and pediatrician. She is a Culshaw Family Junior Investigator and an assistant professor at the Barbara Davis Center for Diabetes, where she sees patients and conducts clinical and translational science research aimed at preventing and curing type 1 diabetes. Her research interests are focused on the development of islet autoimmunity and beta cell dysfunction in children with type 1 diabetes. She is a co-investigator on the BDC prevention team at the Barbara Davis Center. Additionally, Dr. Triolo collaborates clinically with the Children’s Hospital of Colorado Pediatric Gastroenterology Division to care for children with chronic pancreatitis and islet dysfunction.
Ashok Balasubramanyam, MD, is a professor of medicine in the Division of Endocrinology, Diabetes and Metabolism at Baylor College of Medicine. Dr. Balasubramanyam received his clinical and research training at Baylor and at the Massachusetts General Hospital in Boston. He serves as Vice President for Academic Integration at Baylor and Chief Academic Officer of Baylor-St. Luke’s Medical Center and the Texas Division of the Catholic Health Initiatives network. Dr. Balasubramanyam’s research focuses on the causes of complex metabolic diseases — he holds the Rutherford Chair in Diabetes Research and is known for his work in identifying and characterizing atypical forms of diabetes and disorders of adipose tissue. He is principal investigator of the RADIANT (Rare and Atypical Diabetes Network) project, a consortium funded by the National Institutes of Health to discover and determine the causes of new forms of diabetes, and a member of the Baylor center for the NIH’s Undiagnosed Diseases Network. He has been deeply involved in education at every level of clinical and research training, and currently he serves as Director of Baylor’s Clinical Scientist Training Program. Dr. Balasubramanyam also serves as Chair of the American Board of Endocrinology, Metabolism and Diabetes and a councilor of the American Board of Internal Medicine.
Resources